Talk:NicVAX
 | NicVAX was a Natural sciences good articles nominee, but did not meet the good article criteria at the time. There may be suggestions below for improving the article. Once these issues have been addressed, the article can be renominated. Editors may also seek a reassessment of the decision if they believe there was a mistake. | |||||||||
| ||||||||||
 | A fact from this article appeared on Wikipedia's Main Page in the "Did you know?" column on September 20, 2006. The text of the entry was: Did you know ...that NicVax causes an immune response that prevents nicotine from reaching the brain? | |||||||||
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
Failed GA[edit]
As of [1], the article during this review, I failed this article for Good Article status. The major reason is that the article is still a stub article; thus it is not yet ready for GA. The scope of the subject is not broad enough. For instances, how is the clinical development of the drug? How the drug works? Please also expand more about its side effects. The article only shows the studies of the drug during some experimental trials, what is the current status? Is it already approved to be used clinically? How effective is the drug? .... and many many more. So, when the article is ready, you can renominate it again. As always, if you feel disagree about this review, you may ask for another re-review. — Indon (reply) — 16:01, 20 December 2006 (UTC)